by Ophélie Rostaing | May 22, 2026 | News
New in Communications Chemistry (Nature, 2026) — Our team co-authored a peer-reviewed study that validates what we’ve always believed at Molecular Forecaster: when you build ML tools with real chemistry knowledge, you get results that actually transfer to the...
by Ophélie Rostaing | May 24, 2024 | News
Dear Team, Today, we’re hitting an exciting milestone in our journey—welcoming our tenth team member! This moment marks not just growth in numbers but a significant step in our evolution as a company. Reflecting on our journey, I’m so proud of how far we’ve come. We...
by Ophélie Rostaing | May 13, 2024 | News, Patch Updates
IMPACTS: Addition of four new CYP isoforms for SoM predictions (2A6, 2B6, 2C8, and 2E1). Use of SASA correction factor to improve activation energy assignment. SELECT: Use of Tversky index in addition to Tanimoto coefficient for seach similarity. CONVERT: Can convert...
by Ophélie Rostaing | Feb 28, 2024 | News
In the quest for new medicines, developers seek to make AI their divining rod. Petrina Kamya may be a biochemist, but the research and development centre she runs in Montreal is conspicuously devoid of lab coats, test tubes or chemicals. Instead, the newly...
by Ophélie Rostaing | Jan 17, 2024 | News
Molecular Forecaster Inc. Partners with NMX Research and Solutions Inc. to Deliver Expanded Hypothesis-Driven Drug Design Services MONTREAL, QUEBEC, January 17, 2024 – Molecular Forecaster Inc. (MFI) is excited to announce a new partnership with NMX Research and...
